A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
about
Effect of amifostine in head and neck cancer patients treated with radiotherapy: a systematic review and meta-analysis based on randomized controlled trialsPost-radiation dental index: development and reliabilityA phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244).
P2860
A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A phase II study to assess the ...... for parotid salivary sparing.
@en
A phase II study to assess the ...... for parotid salivary sparing.
@nl
type
label
A phase II study to assess the ...... for parotid salivary sparing.
@en
A phase II study to assess the ...... for parotid salivary sparing.
@nl
prefLabel
A phase II study to assess the ...... for parotid salivary sparing.
@en
A phase II study to assess the ...... for parotid salivary sparing.
@nl
P1433
P1476
A phase II study to assess the ...... for parotid salivary sparing.
@en
P2093
Mark S Chambers
Randal S Weber
P356
10.1053/J.SEMINONCOL.2004.12.008
P433
6 Suppl 18
P577
2004-12-01T00:00:00Z